Category: Blog

MGF (Mechano Growth Factor) is a liver-secreted peptide that can sometimes be referred to as IGF-1Ec or IGF-1Eb.  It has a molecular formula is C₁₂₁H₂₀₀N₄₂O_39, and it has a molecular weight of 2888.16.

MGF (Mechano Growth Factor) and the Functionality of Cellular Units

According to scientific study that has been based on animal test subjects, it has been determined that MGF (Mechano Growth Factor)’s overall operational mechanics enable it to do the following trio of processes:

• Provide an inhibition of terminal differentiation – It has been shown that MGF (Mechano Growth Factor) slows down the last stage of the cellular differentiation process, which is the part of the cellular life cycle in which the cell loses its sense of overall functionality.  Because of this inhibition process, the peptide can enable the cellular unit to experience a longer interval of performance.
• Provide an enhanced level of myoblast proliferation – It has been determined that the peptide can increase the instance of the creation and building of muscular and skeletal tissue.  This particular trait can be directly linked to its ability to provide a boost in the secretions that have been shown to play an instrumental part in muscle and tissue growth and repair.

Further scientific study that has been based on animal test subjects has determined that the expression of MGF (Mechano Growth Factor) occurs in a non-uniform manner, as it is expressed in different tissues or in response to various differing stimuli.  It has also been shown to display preferences in regards to the signal transduction pathways that they activate.

What this Functionality Means

Because of the way in which MGF (Mechano Growth Factor) has been shown to operate, scientific study that has been based on animal test subjects has been able to link a host of theorized benefits to the peptide.  Several of these particular benefits can be directly associated with the way in which MGF (Mechano Growth Factor) is able to extend the half-life of secretions as they relate to muscle and tissue cells as well as its ability to block terminal differentiation.

It  has been thought that MGF (Mechano Growth Factor)’s ability to provide a more efficient means of skeletal tissue growth and repair can translate to an elevated process for bone minerals to be produced internally.  This conceptualized boosted process would enable the bones within an animal test subject to become denser on a quicker basis.  This boost in density would then translate to bones that are sturdier and less vulnerable to breaks and fractures.

Another benefit that has been hypothetically associated with MGF (Mechano Growth Factor) is in relation to the treatment of an ischemic injury.  Because of the way in which it can choose the signal transduction pathways that it can activate, studies have been able to hypothesize that this ability could enable it to aid in providing an extra measure of stabilization within an animal test subject’s body in the aftermath of an ischemic episode.  These particular types of episodes include stroke, cardiac arrest due to a heart attack, angina pectoris, or a lack of oxygen delivered to an effected area in the wake of a traumatic injury.

PDF View/Download

The polypeptide IGF-1 LR3, also known as Long r3 igf-1, has a molecular structure of C₉₉₀H₁₅₂₈N₂₆₂O₃₀₀S₇ and a molecular weight of 9200.  It is made up of a chain of 83 amino acids, and sometimes gets mixed up with the peptide chain Long r2 ifg-1 because it has a similar molecular build and similar structural properties.

IGF-1 LR3 and the Liver

Scientific study that has been based on animal test subjects has determined that IGF-1 LR3’s functionality can be partially traced to the relationship that it has with the liver.  This vital organ is primarily responsible for regulating an animal test subject’s detoxification, digestion, and protein synthesis processes.  Specifically, the association with the organ can be tied to the expression of a specific secretion known as IGF-1, also known as Insulin-like Growth Factor-1 or Somatomedin C.  The downside of this secretion is its rapid half-life, which only lasts for around 20 minutes.  However, it has been determined that the presence of IGF-1 LR3 can significantly boost this half-life to an interval of time that lasts around 20 hours.

IGF-1 LR3 and the Pancreas

Further scientific study that has been based on animal test subjects has also determined that IGF-1 LR3’s sense of operational mechanics can also be partially tied to the pancreas.  This is the glandular organ and key member of the endocrine system that has been shown to play a key role in the production of hormones as they relate to an animal test subject’s overarching functional processes.  Specifically, the peptide’s relationship with the pancreas is completely tied to its production of insulin; the secretion whose expression is responsible for enabling the cells in the liver, skeletal muscles, and fat tissues to absorb glucose from the bloodstream in a proper manner.  IGF-1 LR3 has been shown to help this absorption process along by acting to accelerate insulin transport throughout an animal test subject’s bloodstream.

What IGF-1 LR3’s Function Means

This process of elevated glucose transport that IGF-1 LR3 can influence through its relationship with the pancreas has a direct impact on its relationship with the liver.  Because it has been shown to lengthen the functionality of the liver-based secretion IGF-1, this boosted interval of action is fueled by the peptide’s ability to provide it with the fuel that it needs on a more efficient basis.  Ultimately, this has led scientific study based on animal test subjects to note that the peptide has the faculty to produce an increased synthesis of proteins and RNA as well as a decrease in protein degradation.

Because of these elevated processes, scientific study that has been based on animal test subjects has determined that IGF-1 LR3 can be linked to a trio of hypothetical benefits.  These benefits are:

• An increased measure of endurance – Scientific study that has been conducted on animal test subjects have determined that IGF-1 LR3’s properties regarding the promotion of protein synthesis and its ability to block protein degradation enables an animal test subject to experience a more consistent measure of physical activity at an increased interval of time before the negative effects of fatigue begin to kick in.
• An increase in muscle retention – Because IGF-1 LR3 has been shown to extend the half-life of the secretion IGF-1, it can inevitably influence a longer period of the secretions that regulate muscular repair and growth to occur.  Therefore, studies have determined that the results of this extended half-life can cause an increased capacity for an animal test subject to maintain its muscular shape and tone.
• A more efficient means of injury recovery – IGF-1 LR3’s ability to extend the half-life of IGF-1 has enabled scientific study based on animal test subjects to determine it ultimately promotes an elevated rate of repair amongst muscles, tissues, and skeletal structures.  As such, it has been thought that it could play a vital role in enabling an animal test subject to heal from a muscle or bone-related injury faster.

While plenty of research has been conducted regarding the overall functionality and mechanics of IGF-1 LR3, the peptide is still solely intended for the use of scientific study.  Specifically, any research and the subsequent results of such research have solely been built on scientific study that has been based on animal test subjects.  Thus, it needs to be emphasized that any observations in relation to IGF-1 LR3’s overall functionality or mechanics should be contained to a controlled environment like a medical research facility or a laboratory only.

PDF View/Download

The gonadotrophin-releasing hormone agonist GnRH (Triptorelin) is a peptide that is comprised of a chain of 10 amino acids.  This structure enables it to be considered a decapeptide.  It can sometimes be known as Diphereline, Gonapeptyl, Decapeptyl, and Variopeptyl.  It possesses a molecular mass of 1311.5, and its molecular formula is C₆₄H₈₂N₁₈O_13. 

GnRH (Triptorelin) and the Regulation of Hormones

GnRH (Triptorelin)’s primary method of functionality and operational mechanics according to scientific study that has been conducted on animal test subject relates to the pituitary gland.  Located at the bottom of the hypothalamus at the base of the brain, this tiny gland more or less acts like the central command center for an animal test subject’s endocrine system, as it is responsible for regulating and controlling a host of systematic processes.  Some of the processes it controls include:

• Regulation of growth
• Functionality of the thyroid gland
• Measures of pain relief
• Regulation metabolism
• Regulation of temperature
• Functionality of sex organs

Studies have indicated that GnRH (Triptorelin)’s functionality enables it to induce a constant stimulation of the pituitary gland in animal test subjects.  As it does this, studies have indicated that its functionality causes the lowering of two key secretions that are expressed by the pituitary gland as a means of providing growth regulation.

The first of these secretions is luteinizing hormone.  This particular hormone is charged with the regulation and control of estrogen production in female animal test subjects, and it is charged with the regulation and control of testosterone production in male animal test subjects.  It also has been shown to play a vital role in the regulation and control of the reproductive process.

The second of these secretions is follicle-stimulating hormone.  This is the hormone that is responsible for the regulation and control of the development, growth, and pubertal maturation within animal test subjects.  Much like luteinizing hormone, it too plays a vital role in the regulation and control of the reproductive process.

The Results of this Process

In essence, because of the way in which GnRH (Triptorelin) has been shown to function, scientific study that has been conducted on animal test subjects has been able to determine that the peptide can be linked to several potentially positive processes relating to negative conditions spurred on by hormones.

The first of these processes involves GnRH (Triptorelin)’s possible role in aiding in the treatment of hormone-responsive cancers.  This is primarily due to the fact that certain forms of cancers, such as prostate and breast cancers have been at least partially linked to the presence of luteinizing hormone when it is secreted – specifically, the levels of estrogen and testosterone levels that the secretion is shown to influence.  Because GnRH (Triptorelin) has the capacity to inhibit the production of luteinizing hormones in animal test subjects, it has been thought that the presence of the peptide could be used in order to stem or slow the effects of the cancers that have been linked to the hormones’ secretions.

• Additionally, GnRH (Triptorelin)’s ability to inhibit the production of luteinizing hormone has been hypothetically linked to being an aid in the treatment of estrogen-dependent conditions.
• Two conditions particularly stand out in this regard.  The first condition is known as endometriosis.
• This is a gynecological issue in which cells from the uterus lining appear and proliferate on the outside of the uterine cavity.  This condition is marked by severe pain and in some cases, infertility.
• The second condition is known as uterine fibroid.  This issue is marked by a benign tumor that originates from smooth muscle tissue and clusters within the uterus.
• This condition is typically marked by severe pain upon menstruation as well as painful sexual intercourse.

A third potential association regarding GnRH (Triptorelin) has to do with the treatment of precocious puberty.  This is the hormone-related condition in which the onset of pubertal maturation occurs at an unusually early age.  Because the peptide has shown an ability to inhibit the release of follicle-stimulating hormone, which regulates pubertal maturation in animal test subjects, it is thought that this inhibition can lead to a more grounded level of homeostasis within the animal test subject in terms of this form of maturation.